Latest news
Loading news…
Xeris Biopharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Chicago, Illinois, United States Founded 2005 251-500 employees For Profit
Xeris Biopharma is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
364
Ticker
XERS
NASDAQ
Patents
58
25 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- XERS
- Exchange
- NASDAQ
- IPO date
- Jun 20, 2018
- Raised at IPO
- $86M
- Valuation at IPO
- $296M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 14
- Active products
- 28
- Patents granted
- 58
- Trademarks
- 25
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $6M
Company Info
- Founded
- 2005
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 167
- HQ
- Chicago, Illinois, United States
- Region
- Greater Chicago Area, Great Lakes, Midwestern US
- Exit date
- Jun 20, 2018
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.5
- Trend (30d)
- 0
- Trend (90d)
- 7.7
- Last leadership hire
- Jul 1, 2026
Acquisitions by Xeris Biopharma
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Xeris Biopharma
Chief Operating Officer and President
Chairman & CEO
Vice President, Marketing
Senior Vice President of Investor Relations and Corporate Communications
Senior Vice President, General Counsel & Corporate Secretary
SVP, Global Operations & Business Development
Senior Vice President
364
professional contacts at Xeris Biopharma
Contact execs at Xeris Biopharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Xeris Biopharma
Loading news…
FAQs about Xeris Biopharma
People who checked this page also checked these
Sectors Xeris Biopharma invests & acquires in
Browse the full Acquirezy directory.